Intestia Liquid
NDC Package 55714-4822-1
Package Information
Intestia (echinacea, iris versicolor, urtica urens, arsenicum album, baptisia tinctoria, bryonia, cinchona officinalis, collinsonia canadensis, dioscorea villosa, i odium, iris versicolor, lachesis mutus, lycopodium clavatum, natrum carbonicum, natrum muriaticum, nux vomica, phosphorus, podophyllum peltatum, pulsatilla, rhus toxicodendron, pyrogenium) liquids is formulated for associated symptoms such as diarrhea, indigestion, fever, cramping, nausea and vomiting. This formulation utilizes a liquid delivery system. Marketed by Newton Laboratories, Inc., this product is identified by NDC 55714-4822.
Identification & Billing
Clinical Specifications
- ANEMONE PULSATILLA 15 [hp_X]/mL
- ARSENIC TRIOXIDE 15 [hp_X]/mL
- BAPTISIA TINCTORIA ROOT 15 [hp_X]/mL
- BRYONIA ALBA ROOT 15 [hp_X]/mL
- CINCHONA OFFICINALIS BARK 15 [hp_X]/mL
- COLLINSONIA CANADENSIS ROOT 15 [hp_X]/mL
- DIOSCOREA VILLOSA TUBER 15 [hp_X]/mL
- ECHINACEA, UNSPECIFIED 6 [hp_X]/mL
- IODINE 15 [hp_X]/mL
- IRIS VERSICOLOR ROOT 15 [hp_X]/mL
- LACHESIS MUTA VENOM 15 [hp_X]/mL
- LYCOPODIUM CLAVATUM SPORE 15 [hp_X]/mL
- PHOSPHORUS 15 [hp_X]/mL
- PODOPHYLLUM 15 [hp_X]/mL
- RANCID BEEF 30 [hp_X]/mL
- SODIUM CARBONATE 15 [hp_X]/mL
- SODIUM CHLORIDE 15 [hp_X]/mL
- STRYCHNOS NUX-VOMICA SEED 15 [hp_X]/mL
- TOXICODENDRON PUBESCENS LEAF 15 [hp_X]/mL
- URTICA URENS 6 [hp_X]/mL
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Seed Storage Proteins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 55714 - Newton Laboratories, Inc.
- 55714-4822 - Intestia
- 55714-4822-1 - 30 mL in 1 BOTTLE, GLASS
- 55714-4822 - Intestia
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 55714-4822-1 identifies a specific commercial package of 30 ml in 1 bottle, glass of Intestia, a human over the counter drug labeled by Newton Laboratories, Inc.. This liquid is formulated for oral use and contains anemone pulsatilla; arsenic trioxide; baptisia tinctoria root; bryonia alba root; cinchona officinalis bark; collinsonia canadensis root; dioscorea villosa tuber; echinacea, unspecified; iodine; iris versicolor root; lachesis muta venom; lycopodium clavatum spore; phosphorus; podophyllum; rancid beef; sodium carbonate; sodium chloride; strychnos nux-vomica seed; toxicodendron pubescens leaf; urtica urens as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Newton Laboratories, Inc. on September 02, 2019. The current certification is valid through December 31, 2026.
How is this Newton Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 55714482201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.